A. V. Biankin | Wu Lab

Latest

Accelerating cancer omics and precision oncology in health care and research: a Lancet Oncology Commission
ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-beta signalling
Hypermutation In Pancreatic Cancer
Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling
Sirtuin 1 stimulates the proliferation and the expression of glycolysis genes in pancreatic neoplastic lesions
Pancreas-Specific Sirt1-Deficiency in Mice Compromises Beta-Cell Function without Development of Hyperglycemia
SOX9 regulates ERBB signalling in pancreatic cancer development
Whole genomes redefine the mutational landscape of pancreatic cancer
Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling
Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor beta Signaling
Targeting mTOR dependency in pancreatic cancer
Clinical and molecular characterization of HER2 amplified-pancreatic cancer
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater
Neuropilin-2 Promotes Extravasation and Metastasis by Interacting with Endothelial alpha5 Integrin
Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
PINA v2.0: mining interactome modules
qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles
RON is not a prognostic marker for resectable pancreatic cancer